SBFMW Sunshine Biopharma Inc. - Warrant
0.0540USD+74.19%Mkt Cap: —P/E: —6d ago
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)35.35M USD
Gross Profit12.26M USD
Net Income (TTM)-5.98M USD
Revenue/Share49.67 USD
Last Price0.0540 USD
Fiscal Year End—
MR Quarter—
Employees50
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-2.21
EPS (Forward)—
52W Range
0.031043% of range0.0851
52W High0.0851 USD
52W Low0.0310 USD
Profitability
Gross Margin33.76%
Oper. Margin-17.41%
EBITDA Margin-13.72%
Profit Margin-16.46%
ROE-25.94%
ROA-19.87%
Growth
Revenue Growth-1.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.33M USD
CapEx (TTM)836.31K USD
FCF Margin-5.69%
FCF Yield—
Net Debt-13.35M USD
Net Debt/EBITDA2.75
Balance Sheet
Debt/Equity0.04
Current Ratio5.46
Quick Ratio3.21
Book Value/Sh11.52 USD
Cash/Share3.62 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float3.81M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.35
S&P 52W Chg15.78%
Avg Vol (30d)1.61K
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—